{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:30:18Z","timestamp":1761766218075,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.breast.2017.06.018","type":"journal-article","created":{"date-parts":[[2017,6,30]],"date-time":"2017-06-30T09:01:35Z","timestamp":1498813295000},"page":"S1-S4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"S1","title":["De-escalating and escalating surgery in the management of early breast cancer"],"prefix":"10.1016","volume":"34","author":[{"given":"Monica","family":"Morrow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2017.06.018_bib1","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1001\/jamaoncol.2015.2510","article-title":"Breast cancer mortality after a diagnosis of ductal carcinoma in situ","volume":"1","author":"Narod","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.breast.2017.06.018_bib2","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1200\/JCO.2015.65.1869","article-title":"Patient prognostic score and associations with survival improvement offered by radiotherapy after breast-conserving surgery for ductal carcinoma in situ: a population-based longitudinal cohort study","volume":"34","author":"Sagara","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2017.06.018_bib3","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv263","article-title":"Trends in treatment patterns and outcomes for ductal carcinoma in situ","volume":"107","author":"Worni","year":"2015","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.breast.2017.06.018_bib4","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1001\/jama.2009.1450","article-title":"Surgeon recommendations and receipt of mastectomy for treatment of breast cancer","volume":"302","author":"Morrow","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.breast.2017.06.018_bib5","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1245\/s10434-015-4740-8","article-title":"Decreasing recurrence rates for ductal carcinoma in situ: analysis of 2996 women treated with breast-conserving surgery over 30 years","volume":"22","author":"Subhedar","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2017.06.018_bib6","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1245\/s10434-016-5449-z","article-title":"Society of surgical oncology-american society for radiation oncology-american society of clinical oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in ductal carcinoma in situ","volume":"23","author":"Morrow","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2017.06.018_bib7","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.prro.2016.06.011","article-title":"Society of surgical oncology-american society for radiation oncology-american society of clinical oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in ductal carcinoma in situ","volume":"6","author":"Morrow","year":"2016","journal-title":"Pract Radiat Oncol"},{"issue":"33","key":"10.1016\/j.breast.2017.06.018_bib8","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1200\/JCO.2016.68.3573","article-title":"Society of surgical oncology-american society for radiation oncology-american society of clinical oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in ductal carcinoma in situ","volume":"34","author":"Morrow","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2017.06.018_bib9","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1245\/s10434-016-5446-2","article-title":"The association of surgical margins and local recurrence in women with ductal carcinoma in situ treated with breast-conserving therapy: a meta-analysis","volume":"23","author":"Marinovich","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2017.06.018_bib10","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/jnci\/djr027","article-title":"Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS","volume":"103","author":"Wapnir","year":"2011","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.breast.2017.06.018_bib11","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/SLA.0000000000001454","article-title":"Relationship between margin width and recurrence of ductal carcinoma in situ: analysis of 2996 women treated with breast-conserving surgery for 30 years","volume":"262","author":"Van Zee","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.breast.2017.06.018_bib12","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1245\/s10434-009-0765-1","article-title":"What is an adequate margin for breast-conserving surgery? Surgeon attitudes and correlates","volume":"17","author":"Azu","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2017.06.018_bib13","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1245\/s10434-014-3481-4","article-title":"Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer","volume":"21","author":"Moran","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"Suppl 3","key":"10.1016\/j.breast.2017.06.018_bib14","doi-asserted-by":"crossref","first-page":"S422","DOI":"10.1245\/s10434-015-4829-0","article-title":"Impact of consensus guidelines by the society of surgical oncology and the american society for radiation oncology on margins for breast-conserving surgery in stages 1 and 2 invasive breast cancer","volume":"22","author":"Chung","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2017.06.018_bib15","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1245\/s10434-016-5397-7","article-title":"Early adoption of the SSO-ASTRO consensus guidelines on margins for breast-conserving surgery with whole-breast irradiation in stage I and II invasive breast cancer: initial experience from memorial sloan kettering cancer center","volume":"23","author":"Rosenberger","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2017.06.018_bib16","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial","volume":"305","author":"Giuliano","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.breast.2017.06.018_bib17","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/SLA.0000000000001863","volume":"264","author":"Giuliano","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.breast.2017.06.018_bib18","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1245\/s10434-013-2917-6","article-title":"The exportability of the ACOSOG Z0011 criteria for omitting axillary lymph node dissection after positive sentinel lymph node biopsy findings: a multicenter study","volume":"20","author":"Delpech","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2017.06.018_bib19","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.ejso.2012.04.018","article-title":"The post ACOSOG Z0011 era: does our new understanding of breast cancer really change clinical practice?","volume":"38","author":"Guth","year":"2012","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.breast.2017.06.018_bib20","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/ans.12388","article-title":"Relevance of the american college of surgeons oncology group Z0011 trial to breast cancer in the australian setting","volume":"83","author":"Ngui","year":"2013","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.breast.2017.06.018_bib21","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.ejso.2016.05.007","article-title":"Potential impact of application of Z0011 derived criteria to omit axillary lymph node dissection in node positive breast cancer patients","volume":"42","author":"Verheuvel","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.breast.2017.06.018_bib22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jamcollsurg.2012.09.005","article-title":"Impact of the american college of surgeons oncology group Z0011 criteria applied to a contemporary patient population","volume":"216","author":"Yi","year":"2013","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.breast.2017.06.018_bib23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1245\/s10434-013-3200-6","article-title":"Axillary dissection can be avoided in the majority of clinically node-negative patients undergoing breast-conserving therapy","volume":"21","author":"Dengel","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2017.06.018_bib24","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000002354","article-title":"Axillary dissection, nodal recurrence and extent of RT in Z0011 eligible breast cancer patients: a prospective study (abstract No. 54)","author":"Morrow","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.breast.2017.06.018_bib25","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1245\/s10434-016-5259-3","article-title":"Age and receptor status do not indicate the need for axillary dissection in patients with sentinel lymph node metastases","volume":"23","author":"Mamtani","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2017.06.018_bib26","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1200\/JCO.1997.15.7.2483","article-title":"Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18","volume":"15","author":"Fisher","year":"1997","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2017.06.018_bib27","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1200\/JCO.2008.18.3228","article-title":"Sentinel lymph node biopsy after neoadjuvant chemotherapy for advanced breast cancer: results of Ganglion Sentinelle et Chimiotherapie Neoadjuvante, a French prospective multicentric study","volume":"27","author":"Classe","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2017.06.018_bib28","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/SLA.0b013e3181b8fd5e","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients","volume":"250","author":"Hunt","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.breast.2017.06.018_bib29","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","article-title":"Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study","volume":"33","author":"Boileau","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2017.06.018_bib30","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial","volume":"310","author":"Boughey","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.breast.2017.06.018_bib31","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1245\/s10434-016-5246-8","article-title":"How often does neoadjuvant chemotherapy avoid axillary dissection in patients with histologically confirmed nodal Metastases? Results of a prospective study","volume":"23","author":"Mamtani","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2017.06.018_bib32","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/SLA.0000000000000924","article-title":"Tumor biology correlates with rates of breastconserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer findings from the ACOSOG Z1071 (alliance) prospective multicenter clinical trial","volume":"260","author":"Boughey","year":"2014","journal-title":"Ann Surg"},{"key":"10.1016\/j.breast.2017.06.018_bib33","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2017.06.018_bib34","doi-asserted-by":"crossref","unstructured":"Petruolo O, Pilewskie M, Patil S, Stempel M, Barrio A, Morrow M. Can Standard Pathologic Features be Used to Identify a Subset of Estrogen Positive, HER2 Negative Tumors Likely to Benefit from Neoadjuvant Chemotherapy? In: Presented at the 2017 Society of Surgical Oncology Annual Cancer Symposium, March 15-18, 2017, Seattle, Washington.","DOI":"10.1245\/s10434-017-5898-z"},{"key":"10.1016\/j.breast.2017.06.018_bib35","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1200\/JCO.2005.02.0818","article-title":"Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer","volume":"23","author":"Gianni","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2017.06.018_bib36","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s10549-015-3613-y","article-title":"A\u00a0phase II trial of ixabepilone and cyclophosphamide as neoadjuvant therapy for patients with HER2-negative breast cancer: correlation of pathologic complete response with the 21-gene recurrence score","volume":"154","author":"Yardley","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2017.06.018_bib37","doi-asserted-by":"crossref","unstructured":"Pilewskie M, Mamtani A, Barrio A, Zabor E, Stempel M, Morrow M. The Optimal Treatment Plan to Avoid Axillary Lymph Node Dissection in Early-Stage Breast Cancer Patients Differs by Tumor Subtype. In: Presented at the 2017 Society of Surgical Oncology Annual Cancer Symposium, March 15-18, 2017, Seattle, Washington.","DOI":"10.1245\/s10434-017-6016-y"},{"key":"10.1016\/j.breast.2017.06.018_bib38","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1097\/PRS.0000000000001276","article-title":"Bilateral mastectomy versus breast-conserving surgery for early-stage breast cancer: the role of breast reconstruction","volume":"135","author":"Albornoz","year":"2015","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.breast.2017.06.018_bib39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/jamasurg.2014.2895","article-title":"Nationwide trends in mastectomy for early-stage breast cancer","volume":"150","author":"Kummerow","year":"2015","journal-title":"JAMA Surg"},{"key":"10.1016\/j.breast.2017.06.018_bib40","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1200\/JCO.2005.06.217","article-title":"Patient involvement in surgery treatment decisions for breast cancer","volume":"23","author":"Katz","year":"2005","journal-title":"J\u00a0Clin Oncol"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977617304903?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977617304903?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:37:33Z","timestamp":1760776653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977617304903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":40,"alternative-id":["S0960977617304903"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2017.06.018","relation":{},"ISSN":["0960-9776"],"issn-type":[{"type":"print","value":"0960-9776"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"De-escalating and escalating surgery in the management of early breast cancer","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2017.06.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}